Published in Cancer on August 01, 1976
Impairement of thymus derived rosette forming cells during photochemotherapy (psoralen--U.V.A.). Arch Dermatol Res (1978) 0.90
Narrowband ultraviolet B phototherapy of early stage mycosis fungoides in korean patients. Ann Dermatol (2011) 0.90
Decreased circulating E rosette forming cells in psoralen UVA treated patients. Arch Dermatol Res (1977) 0.83
Photochemotherapy in mycosis fungoides. Br Med J (1977) 0.82
Photopheresis: a new therapeutic concept. Yale J Biol Med (1990) 0.78
[Semen analysis under photochemotherapy (PUVA-therapy) (author's transl)]. Arch Dermatol Res (1979) 0.77
Photochemotherapy in psoriasis: a review. J R Soc Med (1979) 0.77
Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma. J Clin Invest (1990) 0.76
Mycosis fungoides--unsolved problems. Br Med J (1979) 0.75
Innovative therapy of cutaneous T-cell lymphoma: beyond psoralen and ultraviolet light and nitrogen mustard. Dermatol Clin (2010) 0.75
Management of mycosis fungoides. J R Soc Med (1979) 0.75
Serotonin signalling is crucial in the induction of PUVA-induced systemic suppression of delayed-type hypersensitivity but not local apoptosis or inflammation of the skin. Exp Dermatol (2016) 0.75
Treatment of cutaneous T-cell lymphoma with a new aromatic retinoid (Ro 10-9359). Arch Dermatol Res (1982) 0.75
Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science (1983) 8.45
The optics of human skin. J Invest Dermatol (1981) 4.41
Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med (1974) 4.38
Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science (1980) 3.06
Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med (1979) 2.71
Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol (1977) 2.53
Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med (1967) 2.38
Treatment of children with port-wine stains using the flashlamp-pulsed tunable dye laser. N Engl J Med (1989) 2.30
Phototesting and dosimetry for photochemotherapy. Br J Dermatol (1977) 2.17
Evaluation of topical agents that prevent sunburn--superiority of para-aminobenzoic acid and its ester in ethyl alcohol. N Engl J Med (1969) 2.13
Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med (1977) 2.06
Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J (2001) 1.95
Photoageing: mechanism, prevention and therapy. Br J Dermatol (2007) 1.94
Photochemotherapy for psoriasis with orally administered methoxsalen. Arch Dermatol (1976) 1.89
Narrower margins for clinical stage I malignant melanoma. N Engl J Med (1982) 1.82
Primary melanoma of the skin: recognition and management. J Am Acad Dermatol (1980) 1.82
Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol (1981) 1.76
Erythema and melanogenesis action spectra of normal human skin. Photochem Photobiol (1982) 1.74
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg (1982) 1.72
Human melanogenesis is stimulated by diacylglycerol. J Invest Dermatol (1989) 1.71
Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest (1997) 1.66
Photoaging/photodamage and photoprotection. J Am Acad Dermatol (1990) 1.63
Cutaneous hypersensitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma. Ann Intern Med (1967) 1.62
Mechanism of depigmentation by hydroquinone. J Invest Dermatol (1974) 1.62
E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci (1994) 1.59
Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin. Lasers Surg Med (1981) 1.57
Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol (1991) 1.54
SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit. FASEB J (2001) 1.54
Topically applied diacylglycerols increase pigmentation in guinea pig skin. J Invest Dermatol (1995) 1.52
Effect of aging and habitual sun exposure on the genetic response of cultured human keratinocytes to solar-simulated irradiation. J Invest Dermatol (1992) 1.52
Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med (1972) 1.49
DNA damage enhances melanogenesis. Proc Natl Acad Sci U S A (1996) 1.48
The natural break points for primary-tumor thickness in clinical Stage I melanoma. N Engl J Med (1981) 1.45
Transmittance of nonionizing radiation in human tissues. Photochem Photobiol (1981) 1.44
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. Cancer J (2000) 1.41
Treatment of psoriasis with long-wave ultraviolet light. Arch Dermatol (1977) 1.39
Enhancing the carotenoid content of atherosclerotic plaque: implications for laser therapy. J Vasc Surg (1989) 1.38
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg (1981) 1.38
Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci (2009) 1.38
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg (1982) 1.38
Sun exposure habits in patients with cutaneous melanoma: a case control study. J Dermatol Surg Oncol (1983) 1.37
The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt. Drugs Exp Clin Res (1985) 1.35
Prospective study of outpatients with extensive colitis. Lancet (1974) 1.34
Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg (1981) 1.34
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery (1981) 1.33
Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc Natl Acad Sci U S A (1997) 1.33
Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J (2000) 1.30
Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA (1987) 1.30
Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. N Engl J Med (1982) 1.29
Some aspects of melanin biology: 1950-1975. J Invest Dermatol (1976) 1.29
p53 is essential for chemotherapy-induced hair loss. Cancer Res (2000) 1.29
Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J Cell Physiol (1987) 1.28
Components of the Goeckerman regimen. J Invest Dermatol (1979) 1.27
Racial differences in the fate of melanosomes in human epidermis. Nature (1969) 1.27
A fine-structure study of the human epidermal melanosome complex and its acid phosphatase activity. J Ultrastruct Res (1968) 1.26
White leaf-shaped macules. Earliest visible sign of tuberous sclerosis. Arch Dermatol (1968) 1.26
Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med (1984) 1.25
Fragmentation of biliary calculi with tunable dye lasers. Gastroenterology (1987) 1.25
DNA damage and melanogenesis. Nature (1994) 1.25
Ultrastructure of giant pigment granules (macromelanosomes) in the cutaneous pigmented macules of neurofibromatosis. J Invest Dermatol (1973) 1.24
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. Ann Surg (1982) 1.24
Action spectrum for phototherapy of psoriasis. J Invest Dermatol (1981) 1.23
Accuracy of dermatologic diagnosis by television. Arch Dermatol (1972) 1.21
The human sunburn reaction: histologic and biochemical studies. J Am Acad Dermatol (1981) 1.20
Basal cell nevus syndrome. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1966) 1.20
Melanotic macules in Albright's syndrome and in neurofibromatosis. JAMA (1968) 1.20
Sunlight and skin cancer. N Engl J Med (1985) 1.20
Beta-carotene as a photoprotective agent in erythropoietic protoporphyria. N Engl J Med (1970) 1.19
p53 Involvement in the control of murine hair follicle regression. Am J Pathol (2001) 1.19
Observations on the absorption of oral betamethasone 17-valerate and its therapeutic value in ulcerative colitis. Br Med J (1967) 1.18
The effects of indomethacin on long-wave ultraviolet-induced delayed erythema. J Invest Dermatol (1977) 1.18
Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis. Br J Dermatol (1978) 1.16
Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol (1984) 1.14
Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine. Arch Dermatol (1980) 1.13
Lentigo maligna melanoma has no better prognosis than other types of melanoma. J Clin Oncol (1984) 1.12
Mitotic activity in non-neoplastic melanocytes in vivo as determined by histochemical, autoradiographic, and electron microscope studies. J Cell Biol (1975) 1.12
Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte derived factors. J Invest Dermatol (1989) 1.12
Increased concentrations of arachidonic acid, prostaglandins E2, D2, and 6-oxo-F1 alpha, and histamine in human skin following UVA irradiation. J Invest Dermatol (1983) 1.12
Growth of human keratinocytes on fibronectin -coated plates. Cell Biol Int Rep (1980) 1.10
Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas. Arch Dermatol (1993) 1.08
Late recurrence (beyond ten years) of cutaneous malignant melanoma. Report of two cases and a review of the literature. JAMA (1984) 1.08
Tunable pulsed dye laser for the treatment of benign cutaneous vascular ectasia. Dermatologica (1987) 1.08
Hodgkin's disease. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1967) 1.07
Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res (1997) 1.06
The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier. Arch Ophthalmol (1988) 1.06
The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. J Photochem Photobiol B (1992) 1.06
Prolonged ultraviolet light-induced erythema and the cutaneous carcinoma phenotype. J Invest Dermatol (1976) 1.05